Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when TFX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTeleflex launches $250M accelerated share repurchase funded by OEM business sale proceeds
Filed August 7, 2026 · Period ending August 7, 2026 · ~1 min read
Key Changes
-
high
Entered $250M accelerated share repurchase with Truist Bank, representing 25% of the $1B authorization. Will receive 80% of shares upfront on Aug 10 based on Aug 6 closing price, with final share count determined by VWAP during program term.
Item 8.01 verify on EDGAR → -
high
Funding the repurchase entirely with proceeds from the sale of its OEM and Development Services business, redeploying divestiture capital into shareholder returns rather than debt reduction or reinvestment.
Item 8.01 verify on EDGAR → -
medium
ASR scheduled to complete in Q4 2026, though Truist can terminate earlier at its discretion. Final settlement may deliver additional shares or require cash/share true-up depending on price movements during the program.
Item 8.01 verify on EDGAR →
Summary
Teleflex is deploying $250 million from its recent OEM and Development Services business sale into an accelerated share repurchase program with Truist Bank. The company will pay the full amount on August 10 and immediately receive shares worth 80% of the repurchase price, with the final share count determined by volume-weighted average prices through Q4 2026.
This represents a quarter of Teleflex's existing $1 billion buyback authorization. The capital allocation decision is notable: rather than paying down debt or reinvesting in the core medical device business, management is returning the divestiture proceeds directly to shareholders. For investors, this signals confidence in the stock's valuation and a preference for buybacks over other uses of capital.
The ASR structure accelerates the timing compared to open-market purchases, removing shares from the float quickly. The program's completion in Q4 will determine the final share count and any settlement adjustments based on actual trading prices during the term.
Section-by-Section Diff
Event · Item 8.01 — Other Events
Item 8.01 — Other Events filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
The ASR Transaction is scheduled to terminate in the fourth quarter of 2026 but may conclude earlier than its scheduled termination date at the election of the Counterparty. The Company will fund the Repurchase Price with proceeds from the sale of its Original Equipment Manufacturing and Development Services business.
The ASR is scheduled to complete in Q4 2026, though the counterparty can terminate earlier. Teleflex is funding the $250 million repurchase with proceeds from selling its OEM and Development Services business, indicating capital redeployment from a divestiture into shareholder returns.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 10, 2026 · How we verify